Please provide your email address to receive an email when new articles are posted on . Four times daily Yutrepia for 16 weeks led to improvements in walk distance and cardiac effort in patients with ...

The goal of this activity is to educate clinicians on the symptoms and presentation of pulmonary hypertension-interstitial lung disease (PH-ILD) to administer the appropriate diagnostic tests, ...

Photo source: Freepik Interstitial Lung Diseases (ILDs) are often misunderstood and overlooked health issues. Despite their prevalence, ILDs remain unfamiliar to many. So, what exactly are ILDs?

MSD and Daiichi Sankyo have revealed some of the clinical data that prompted them to start pivotal testing of ifinatamab deruxtecan (I-DXd) in patients with previously treated, extensive-stage small ...

Abstract: Headphone listening in applications such as augmented and virtual reality (AR and VR) relies on high-quality spatial audio to ensure immersion, making accurate binaural reproduction a ...

Background: Patients with antimelanoma differentiation–associated gene 5 antibody–positive dermatomyositis–associated interstitial lung disease (anti-MDA5+DM-ILD) are susceptible to rapidly ...

More than 92% of patients treated with Daiichi Sankyo and AstraZeneca’s ENHERTU were free of invasive disease at three years DESTINY-Breast05 presented in ESMO Presidential Symposium I alongside ...

Highest reported pathologic complete response rate seen in a Phase III registrational trial for HER2-positive early breast cancer with favorable safety profile vs. standard treatment DESTINY-Breast11 ...

Background We describe the epidemiology of asthma, chronic obstructive pulmonary disease (COPD) and interstitial lung disease (ILD) from 2004 to 2023 in England, Wales, Scotland and Northern Ireland ...